CRCM
IDXX icon

Crystal Rock Capital Management’s Idexx Laboratories IDXX Stock Holding History

Crystal Rock Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.35M Sell
9,525
-355
-4% -$228K 3.18% 10
2025
Q4 		$6.68M Hold
9,880
– – 3.53% 12
2025
Q3 		$6.31M Sell
9,880
-705
-7% -$428K 3.45% 11
2025
Q2 		$5.68M Sell
10,585
-600
-5% -$287K 3.27% 12
2025
Q1 		$4.7M Buy
11,185
+2,180
+24% +$947K 3.21% 12
2024
Q4 		$3.72M Hold
9,005
– – 2.28% 17
2024
Q3 		$4.55M Buy
9,005
+4,265
+90% +$2.07M 2.68% 14
2024
Q2 		$2.31M Buy
+4,740
New +$2.38M 1.38% 23
2022
Q2 		– Sell
-4,175
Closed -$2.28M – 29
2022
Q1 		$2.28M Sell
4,175
-2,215
-35% -$1.17M 1.51% 26
2021
Q4 		$4.21M Sell
6,390
-275
-4% -$173K 2.27% 19
2021
Q3 		$4.14M Sell
6,665
-785
-11% -$527K 2.2% 21
2021
Q2 		$4.71M Hold
7,450
– – 2.45% 16
2021
Q1 		$3.65M Hold
7,450
– – 1.98% 22
2020
Q4 		$3.72M Hold
7,450
– – 2.13% 21
2020
Q3 		$2.93M Buy
7,450
+500
+7% +$185K 1.85% 23
2020
Q2 		$2.29M Hold
6,950
– – 1.59% 25
2020
Q1 		$1.68M Hold
6,950
– – 1.49% 23
2019
Q4 		$1.81M Hold
6,950
– – 1.18% 28
2019
Q3 		$1.89M Buy
6,950
+1,525
+28% +$424K 1.39% 25
2019
Q2 		$1.49M Buy
+5,425
New +$1.34M 1.1% 26

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Crystal Rock Capital Management's IDXX Position: Q1 2026 in Review

Crystal Rock Capital Management reduced its Idexx Laboratories (IDXX) stake by 3.6% in Q1 2026, selling an estimated $228K and leaving 9,525 shares worth $5.35M. The position accounts for 3.18% of the portfolio, ranked #10.

Crystal Rock Capital Management first reported a position in IDXX in Q2 2019 and has held it in 20 quarters since. The position peaked at $6.68M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Crystal Rock Capital Management held 9,525 shares of Idexx Laboratories worth $5.35M as of Q1 2026.
  • Crystal Rock Capital Management sold 355 Idexx Laboratories shares in Q1 2026, an estimated $228K.
  • Idexx Laboratories made up 3.18% of Crystal Rock Capital Management's portfolio in Q1 2026, its #10 holding.
  • Crystal Rock Capital Management first reported a position in Idexx Laboratories in Q2 2019 and has held it in 20 quarters since.
  • Crystal Rock Capital Management's Idexx Laboratories position peaked at $6.68M in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Crystal Rock Capital Management's 13F filing for Q1 2026, filed 4 May 2026.